Avalo Therapeutics (AVTX) Enterprise Value Growth (3y) (2017 - 2026)
Avalo Therapeutics (AVTX) Enterprise Value Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.74% |
| Dec 31, 2025 | -1,771.57% |
| Sep 30, 2025 | -1,069.35% |
| Jun 30, 2025 | -1,618.02% |
| Mar 31, 2025 | 88.28% |
| Dec 31, 2024 | -1,281.76% |
| Sep 30, 2024 | -693.24% |
| Mar 31, 2024 | 95.29% |
| Dec 31, 2023 | -480.02% |
| Sep 30, 2023 | -325.66% |
| Jun 30, 2023 | 48.21% |
| Mar 31, 2023 | -4.14% |
| Dec 31, 2022 | 87.48% |
| Sep 30, 2022 | 19.66% |
| Jun 30, 2022 | 18.92% |
| Mar 31, 2022 | -33.63% |
| Dec 31, 2021 | -39.64% |
| Sep 30, 2021 | 71.16% |
| Jun 30, 2021 | -1,519.08% |
| Mar 31, 2021 | -1,299.99% |